FacultyFaculty/Author Profile
Jennifer  Gordon

Jennifer Gordon

Paul, Weiss, Rifkind, Wharton & Garrison LLP

New York, NY, USA


Jennifer Gordon is skilled in life sciences-related patent law. She has extensive experience in complex patent litigation involving biotechnology, pharmaceutical and other life sciences and chemistry-related patents. She has tried cases to judges and juries and argued appeals before the Court of Appeals for the Federal Circuit.

EXPERIENCE

Dr. Gordon also has extensive experience in client counseling (including validity, infringement and freedom-to-operate analyses; strategic planning in patent procurement; as well as IP due diligence investigations related to corporate transactions). She has been involved with various patent office proceedings in the United States and abroad, including reexaminations, inter partes reviews and oppositions. She has worked with foreign counsel to coordinate and implement strategies for procuring, enforcing and defending patent rights on a worldwide basis.

Over her career, Dr. Gordon has litigated, procured and counseled on a vast array of patented technologies in the life sciences, such as nucleic acid amplification technologies (PCR), recombinant DNA technologies, cell culture methodologies, biological therapeutics (interferons, human growth hormone, monoclonal antibodies, receptor decoys, stem cells and antisense oligonucleotides), growth factors, enzymes, vaccines, genetically engineered plants, pharmaceutical compounds (cefadroxil, ezetimibe, rosiglitazone, capecitabine and valsartan), medical devices (stents) and medical diagnostics (PCR, in situ hybridization, immunoassays and NMR contrast agents).

Dr. Gordon is a member of the American Intellectual Property Law Association, The Federal Circuit Bar Association, The New York Intellectual Property Law Association, The New Jersey Intellectual Property Law Association, The American Chemical Society and The American Association of the Advancement of Science. She is a frequent lecturer on numerous intellectual property topics, particularly with respect to biotechnology patent law. Ms. Gordon has been named in publications such as Chambers USA.

Jennifer Gordon is associated with the following items:
CHB Chapters  CHB Chapters Section 101: Patentable Subject Matter in the Aftermath of Myriad and Mayo - Developments in Pharmaceutical and Biotech Patent Law 2016, Monday, December 12, 2016
Section 101: Patentable Subject Matter in the Aftermath of Myriad and Mayo - Developments in Pharmaceutical and Biotech Patent Law 2017, Wednesday, November 01, 2017
Web Segment  Web Segment The Evolving Law of Section 101 and Life Sciences Patents - Developments in Pharmaceutical and Biotech Patent Law 2017, Thursday, November 02, 2017
MP3 Audio  MP3 Audio The Evolving Law of Section 101 and Life Sciences Patents - The Evolving Law of Section 101 and Life Sciences Patents, Thursday, November 02, 2017
Transcripts  Transcripts The Evolving Law of Section 101 and Life Sciences Patents - The Evolving Law of Section 101 and Life Sciences Patents, Thursday, November 02, 2017
MP4 - Mobile Video Seg  MP4 - Mobile Video Seg The Evolving Law of Section 101 and Life Sciences Patents - The Evolving Law of Section 101 and Life Sciences Patents, Thursday, November 02, 2017
On-Demand Web Programs  On-Demand Web Programs Developments in Pharmaceutical and Biotech Patent Law 2017, Monday, November 06, 2017, New York, NY
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • GooglePlus
  • RSS

All Contents Copyright © 1996-2017 Practising Law Institute. Continuing Legal Education since 1933.

© 2017 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.